Annual Report and Financials | World Obesity Federation

Annual Report and Financials

The World Obesity Federation receives funding from a variety of sources to support its programmes and core activities. 

We receive significant core funding to support our mission through sales of our journals - Obesity Reviews, Pediatric Obesity, Obesity Science and Practice, and Clinical Obesity - and through SCOPE certification and fees. Further support is provided through our members and income from regional and global congresses including the International Congress on Obesity.

World Obesity receives funding in the form of project and educational grants from sources including Novo Nordisk, Pfizer, Lilly, Medtronic, Johnson & Johnson, Rhythm Pharmaceutical, Vivus, IFA , Boehringer Ingelheim and Wellcome Trust.  We have received support from individual donors and EU Commission funded projects, as well as grants from TCC Foundation and World Heart Federation.

View the World Obesity Federations annual reports and financial documents here. Click to download the required files.

Related Resources

View all

Financials Jul 21, 22

Accounts 2021

View Resource

Reports Financials Jul 21, 22

Annual Report 2021

Annual Review and Report for the World Obesity Federation, for the year ending 31 December 2021

View Resource

Financials Jul 01, 21

Accounts 2020

View Resource

Reports Financials Jul 01, 21

Annual Report 2020

Annual report for the World Obesity Federation, for the year 2020.

View Resource

Jul 29, 20

Accounts 2019

View Resource

Reports Financials Feb 01, 21

Annual Report 2019

Annual report for the World Obesity Federation, for the year 2019.

View Resource

Aug 01, 19

Accounts 2018

View Resource

Dec 01, 19

Annual Report 2018

Our annual summary of our work over the course of 2018.

View Resource